Journal profile · Engineering, Biomedical
Journal of Tissue Engineering and Regenerative Medicine
ISSN 1932-6254 · eISSN 1932-7005 · John Wiley and Sons Ltd · ENGLAND · Bimonthly · Founded 2007
Journal of Tissue Engineering and Regenerative Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.94; fully open access; APC about USD 2,490; median 263 days to acceptance (20 articles, last 24 months); community-reported acceptance: fairly easy; 22 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Tissue Engineering and Regenerative Medicine is published by John Wiley and Sons Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Tissue Engineering and Regenerative Medicine, Mesenchymal stem cell research and Electrospun Nanofibers in Biomedical Applications, together about 37.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Tissue Engineering and Regenerative Medicine publishes rapidly and rigorously peer-reviewed original research papers and reviews on topics relevant to the development of therapeutic approaches which combine stem or progenitor cells, biomaterials and scaffolds, growth factors and other bioactive agents, and their respective constructs. All papers should deal with research that has a direct or potential impact on the development of novel clinical approaches for the regeneration or repair of tissues and organs. The journal is multidisciplinary, covering the combination of the principles of life sciences and engineering in efforts to advance medicine and clinical strategies. The journal focuses on the use of cells, materials, and biochemical/mechanical factors in the development of biological functional substitutes that restore, maintain, or improve tissue or organ function. The journal publishes research on any tissue or organ and covers all key aspects of the field, including the development of new biomaterials and processing of scaffolds; the use of different types of cells (mainly stem and progenitor cells) and their culture in specific bioreactors; studies in relevant animal models; and clinical trials in human patients performed under strict regulatory and ethical frameworks. Manuscripts describing the use of advanced methods for the characterization of engineered tissues are also of special interest to the journal readership. Coverage Includes: Studies on the interactions between cells and constructs are welcome, particularly where they advance our understanding of these processes or provide clear suggestions for improvements to existing systems. Surface modification technologies, their effects on protein adsorption and on cell seeding adhesion and proliferation are of major interest to the journal. Both in vitro and in vivo approaches will be considered, as the journal also aims to focus on in vivo responses to cell-material constructs. Typically, papers presenting the design, development or refinement of biomaterials or scaffolds will only be considered when these have been tested for their ability to support cellular attachment/interaction and/or growth, development and differentiation. The journal also publishes manuscripts dealing with novel approaches to regenerative medicine that apply some type of controlled/sustained release strategy. Papers dealing with the development of carrier systems, cell encapsulation, release of drugs, growth
From the journal's Aims & Scope
Research area (LetPub): Engineering, Biomedical
Editor-in-chief Moulshree KohliPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Tissue Engineering and Regenerative MedicineMedicine14.9%
- Mesenchymal stem cell researchMedicine11.3%
- Electrospun Nanofibers in Biomedical ApplicationsMaterials Science11.2%
- Bone Tissue Engineering MaterialsEngineering9.9%
- Periodontal Regeneration and TreatmentsMedicine6.6%
- 3D Printing in Biomedical ResearchEngineering6.4%
- Osteoarthritis Treatment and MechanismsMedicine5.2%
- Wound Healing and TreatmentsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Cell Biology | Zone 3 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Cell Biology | Zone 4 |
| Minor | Engineering, Biomedical | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedINSPECEmbaseCASPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.94LetPub ·
- Impact factor (publisher)
- 2Publisher website ·
- Impact factor (publisher) 2025
- 2Publisher website ·
- CiteScore 2026-06
- 7.8LetPub ·
- CiteScore (publisher)
- 7.8Publisher website ·
- CiteScore (publisher) 2025
- 7.8Publisher website ·
- SJR 2026-06
- 0.62LetPub ·
- SNIP 2026-06
- 0.68LetPub ·
- h-index
- 59LetPub ·
- h-index
- 112OpenAlex ·
- i10-index
- 1,887OpenAlex ·
- 2-year mean citedness
- 2.6OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 17LetPub ·
- Articles per year (publisher) 2025
- 17Publisher website ·
- Downloads per year (publisher) 2025
- 217,233Publisher website ·
Articles by year OpenAlex count · 2,731 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 5 | 4 | 1 |
| 2025 | 22 | 21 | 43 |
| 2024 | 13 | 12 | 60 |
| 2023 | 37 | 37 | 193 |
| 2022 | 101 | 52 | 1,266 |
| 2021 | 127 | 79 | 1,870 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
263 daysMedian, submission to acceptance · P25–P75 210 days – 316 days
- Acceptance to online
- median 38 days (20 articles)
- Submission to online
- median 318 days
- Sample
- 20 articles with submission and acceptance dates (25 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Acceptance rate (publisher)
- 9%Publisher website ·
- Acceptance rate (publisher) 2025
- 9%Publisher website ·
- Submission to first decision
- 17 daysPublisher website ·
- Submission to first decision 2025
- 17 daysPublisher website ·
- Submission to acceptance 2025
- 271 daysPublisher website ·
- Acceptance to publication 2025
- 33 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,490 / EUR 2,150 / GBP 1,830 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- retractionRETRACTIONLength not stated
- reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
- systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Peer review, Preprints, Trial registration / reporting guidelines
- Authorship Title and authorship information
The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…
Source ↗Publisher website ·- Conflicts of interest Conflicts of interest
Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…
Source ↗Publisher website ·- Data availability Data availability
Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.
Source ↗Publisher website ·- License & copyright Copyright and permissions
Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…
Source ↗Publisher website ·- Peer review Peer review
The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…
Source ↗Publisher website ·- Preprints Preprints
The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley and Sons Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2007
- ISSN
- 1932-6254
- Print ISSN
- 1932-7005
- Electronic ISSN
- 1932-7005
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Tissue Engineering and Regenerative Medicine
What CAS zone is Journal of Tissue Engineering and Regenerative Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Tissue Engineering and Regenerative Medicine is in Zone 4 of Medicine, and in Zone 3 of the minor category Biotechnology & Applied Microbiology / Cell & Tissue Engineering / Cell Biology / Engineering, Biomedical. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Tissue Engineering and Regenerative Medicine?
The latest impact factor listed by LetPub is 1.94; CiteScore 7.8, h-index 112.
How long does peer review take at Journal of Tissue Engineering and Regenerative Medicine?
Based on the dates recorded on 20 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 263 days (interquartile range 210–316 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 9% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Tissue Engineering and Regenerative Medicine?
According to LetPub and DOAJ records, Journal of Tissue Engineering and Regenerative Medicine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, INSPEC, Embase and CAS; that list has not been checked against each database.
Is Journal of Tissue Engineering and Regenerative Medicine open access, and what is the APC?
Journal of Tissue Engineering and Regenerative Medicine is a fully open-access journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .